When do the 2025-2026 EU cosmetic regulation changes take effect?

The changes have staggered effective dates throughout 2025-2027. Omnibus VII CMR bans begin June 2025, INCI updates by October 2025, Vitamin A placement deadline November 2025, zinc pyrithione ban March 2026, fragrance allergen labeling July 2026, and Vitamin A market withdrawal by May 2027. Products already on the market typically have extended transition periods.

What happens to products already on shelves when regulations change?

Most regulations include transition periods allowing existing compliant stock to be sold. However, new production must comply from the effective date. The specific transition period varies by regulation — check each regulation's text for exact timelines. Products non-compliant after transition periods must be withdrawn from the market.

Can I still use retinol in my skincare products?

Yes, but within new concentration limits. Face products may contain maximum 0.3% retinol, body products 0.05%. Retinyl esters are allowed at equivalent concentrations. Products must carry the mandatory warning: 'Contains vitamin A. Consider your daily intake before use.' New products must comply by November 1, 2025; existing non-compliant products must be withdrawn by May 1, 2027.

What alternatives exist for zinc pyrithione in anti-dandruff products?

Common alternatives include pyroctone olamine (Octopirox), salicylic acid, climbazole (until September 2025), ketoconazole (limited use), and natural alternatives like tea tree oil. Each has different efficacy profiles and regulatory status. Safety assessments must be updated for new formulations.

Do I need to update my CPSR for these regulation changes?

Yes. Any reformulation requires CPSR update. Additionally, CPSRs for products containing newly restricted ingredients should document compliance with new concentration limits, even if the formulation itself doesn't change. The safety assessor must verify continued safety under new regulatory requirements.

How do I know which fragrance allergens need labeling?

Regulation 2023/1545 lists all declarable allergens with concentration thresholds (0.001% for leave-on, 0.01% for rinse-off). Your fragrance supplier should provide allergen declarations for their compositions. Natural ingredients like essential oils must be assessed for their allergen content.

Are there small business exemptions from these requirements?

No. Unlike some other regulatory regimes, EU Cosmetics Regulation applies equally to all businesses regardless of size. Small businesses must comply with all ingredient restrictions, labeling requirements, and safety assessment obligations. The only flexibility is in transition period timing.

What are the penalties for non-compliance with new EU cosmetic regulations?

Penalties are set by individual Member States and can include product withdrawal orders, fines, and potential prosecution. Market surveillance authorities actively check compliance. Non-compliant products may be reported through the EU RAPEX system, resulting in EU-wide enforcement action.

EU Cosmetic Regulation Changes 2025-2026: Timeline & Impact

Why 2025-2026 Are Critical Years for EU Cosmetics

The European Union is implementing a wave of regulatory changes that will fundamentally reshape the cosmetics industry. According to European Commission guidance, the period from 2025-2026 represents one of the most significant regulatory transitions since the original Cosmetics Regulation took effect in 2013.

Multiple Deadlines Approaching

Cosmetic brands face overlapping compliance deadlines across Omnibus VII, Omnibus VIII, Vitamin A restrictions, siloxane bans, fragrance allergen labeling, and INCI glossary updates. Failure to track all requirements could result in non-compliant products reaching the market.

These changes affect virtually every aspect of cosmetic formulation and compliance:

Ingredient restrictions — New CMR substance bans and concentration limits
Labeling requirements — Expanded fragrance allergen disclosure
Safety assessments — Updated CPSR requirements for restricted ingredients
INCI nomenclature — Comprehensive glossary update requiring label changes

Omnibus VII (Regulation 2025/877) — CMR Bans

Commission Regulation (EU) 2025/877, commonly called Omnibus VII, introduces significant new restrictions on CMR (Carcinogenic, Mutagenic, Reprotoxic) substances in cosmetics.

Key Substances Banned Under Omnibus VII

Major Omnibus VII Prohibitions
Substance	CAS Number	Common Use	Compliance Date
2-Chloroacetamide	79-07-2	Preservative	June 2025
Triclocarban	101-20-2	Antimicrobial	June 2025
Climbazole	38083-17-9	Anti-dandruff	September 2025
Zinc pyrithione (ZPT)	13463-41-7	Anti-dandruff	March 2026
PFAS compounds (various)	Multiple	Water/oil repellent	2025-2026
Additional coal tar dyes	Multiple	Colorants	June 2025

* Dates indicate when products must be withdrawn from market

* Transition periods may allow sale of compliant stock already manufactured

Zinc Pyrithione Ban

The ban on zinc pyrithione (ZPT) represents a major reformulation challenge for anti-dandruff shampoos. Brands must identify alternative actives — pyroctone olamine (Octopirox) and salicylic acid are common substitutes, though efficacy profiles differ.

CMR Classification Updates

Under Article 15 of Regulation 1223/2009, substances classified as CMR under CLP Regulation are automatically prohibited in cosmetics. Omnibus VII codifies recent CLP classifications into the Cosmetics Regulation annexes.

CMR Classification Impact on Cosmetics
CMR Category	Cosmetic Use	Exceptions
Category 1A (Known CMR)	Prohibited	None
Category 1B (Presumed CMR)	Prohibited	None
Category 2 (Suspected CMR)	Prohibited	SCCS opinion may allow if safe at specific concentrations

Vitamin A & Arbutin Restrictions (Regulation 2024/996)

Commission Regulation (EU) 2024/996 introduces strict concentration limits on retinol, retinyl esters, and alpha-arbutin, effective from 2025.

New Vitamin A Limits

Vitamin A Restrictions Under Regulation 2024/996
Ingredient	Product Type	Maximum Concentration
Retinol	Face products	0.3%
Retinol	Body products	0.05%
Retinyl Palmitate	Face products	0.55% (as retinol equivalent)
Retinyl Acetate	Face products	0.4% (as retinol equivalent)
All Vitamin A forms	Lip products	0.05%
All Vitamin A forms	Sunscreen (face)	0.05%

Vitamin A Compliance Timeline

Two-Phase Compliance Deadlines

Vitamin A restrictions have TWO compliance dates that brands must track: - November 1, 2025: Non-compliant products shall NOT be placed on the EU market - May 1, 2027: Non-compliant products shall NOT be made available on the market (complete withdrawal required)

Vitamin A Compliance Milestones
Milestone	Date	Requirement
Placement deadline	November 1, 2025	New products must comply with concentration limits
Making available deadline	May 1, 2027	All non-compliant products must be withdrawn from shelves

Mandatory Warning Statement

Products containing vitamin A derivatives must display: "Contains vitamin A. Consider your daily intake before use" — this is the official wording per Regulation (EU) 2024/996, Annex III entry 376. Note: The SCCS recommended additional warnings about vulnerable populations (pregnancy, children), but these were NOT incorporated into the binding regulation text.

Alpha-Arbutin Restrictions

Alpha-arbutin, a popular skin brightening agent, is now restricted to maximum 2% concentration in face products. Products must also include warnings about sun exposure.

Cyclic Siloxane Restrictions (D4/D5/D6)

Building on earlier restrictions, the EU has further tightened limits on cyclic siloxanes due to environmental persistence concerns.

Siloxane Concentration Limits
Siloxane	INCI Name	Maximum (Rinse-off)	Maximum (Leave-on)
D4	Cyclotetrasiloxane	0.1%	0.1%
D5	Cyclopentasiloxane	0.1%	0.1%
D6	Cyclohexasiloxane	0.1%	0.1%

* Limits apply to each siloxane individually, not combined

* Many formulations historically used 5-20% D5 in hair products

Major Reformulation Required

The 0.1% limit effectively bans cyclic siloxanes from most cosmetic applications where they provided slip, shine, and volatile carrier functions. Silicone alternatives (linear siloxanes, dimethicone) or non-silicone alternatives must be evaluated.

INCI Glossary Update (Decision 2025/1175)

Implementing Decision (EU) 2025/1175 introduces a comprehensive update to the INCI (International Nomenclature of Cosmetic Ingredients) glossary, requiring label updates across thousands of products.

Key INCI Changes

INCI Glossary 2025 Major Updates

New INCI names for approximately 200 ingredients
Standardized naming conventions for plant extracts
Updated nomenclature for fermented ingredients
New entries for biotechnology-derived ingredients
Clarified naming for nanomaterial forms
Harmonized naming with international standards

Label Compliance Timeline

Products must display the updated INCI names on labels. A transition period allows existing labeled stock to be sold, but new production must use updated names by October 2025.

Fragrance Allergen Deadline (July 2026)

Regulation 2023/1545 significantly expands fragrance allergen labeling requirements, with key deadlines in 2026 and 2028.

Fragrance Allergen Compliance Deadlines
Requirement	Deadline	Impact
Label newly added allergens	July 31, 2026	Products containing new allergens above thresholds must list them
All products must comply	July 31, 2028	Products already on market must update labels

Expanded Allergen List

The regulation expands the list of declarable fragrance allergens from 26 to over 80 substances. This includes:

56 new individual allergens requiring labeling
Natural extracts containing allergens (e.g., essential oils)
Pre-haptens and pro-haptens that convert to allergens

Compliance Timeline Summary

2025-2026 EU Cosmetic Regulation Deadlines
Date	Regulation	Requirement
June 2025	2025/877	Omnibus VII CMR bans (Phase 1)
September 2025	2025/877	Climbazole prohibition
October 2025	2025/1175	INCI glossary updates required on new labels
November 2025	2024/996	Vitamin A — placement deadline (new products must comply)
March 2026	2025/877	Zinc pyrithione (ZPT) ban
July 2026	2023/1545	New fragrance allergen labeling deadline
May 2027	2024/996	Vitamin A — complete market withdrawal deadline
July 2028	2023/1545	All products must comply with allergen labeling

Impact on Formulations

These regulatory changes require systematic review of cosmetic portfolios:

Reformulation Impact by Product Category
Product Category	Primary Impact	Reformulation Priority
Anti-aging skincare	Vitamin A limits	High — most affected category
Anti-dandruff shampoo	ZPT ban	Critical — primary active banned
Hair care (silicones)	D4/D5/D6 limits	High — major ingredient change
Fragranced products	Allergen labeling	Medium — label updates needed
Skin brighteners	Arbutin limits	Medium — concentration adjustments
Preservative systems	CMR bans	Variable — depends on current system

Reformulation Strategies

Managing Multi-Regulatory Compliance

Audit Current Portfolio

Map all products against upcoming restrictions to identify affected formulations.

Prioritize by Deadline

Create timeline-based action plans starting with nearest deadlines.

Evaluate Alternatives

Source and test alternative ingredients before reformulation commitment.

Update Safety Assessments

Ensure CPSRs reflect new formulations and any new ingredient safety data.

Coordinate Label Changes

Batch label updates where possible to minimize print runs and costs.

Key Takeaways

2025-2026 brings multiple overlapping regulatory changes requiring coordinated compliance efforts

Omnibus VII bans zinc pyrithione and other CMR substances with varying compliance dates

Vitamin A faces strict new concentration limits (0.3% face, 0.05% body) — placement deadline November 2025, withdrawal deadline May 2027

Cyclic siloxanes D4/D5/D6 limited to 0.1% effectively requiring reformulation

INCI glossary updates require label changes by October 2025 for new production

Fragrance allergen list expands from 26 to 80+ substances with July 2026 deadline

Early planning and portfolio auditing essential to manage overlapping deadlines

Safety assessments (CPSRs) must be updated for all reformulated products